Immunotherapy in colorectal cancer: rationale, challenges and potential | Nature Reviews Gastroenterology & Hepatology
Clinical trials of immunotherapy in colorectal cancer | Download Scientific Diagram
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?: Molecular Therapy - Oncolytics
Frontiers | Colorectal Cancer Immunotherapy: Options and Strategies | Immunology
Trial to evaluate combination of CAR-T and pembrolizumab for metastatic colorectal cancer
Immunotherapy of colorectal cancer: new perspectives after a long path | Immunotherapy
Colorectal Cancer Clinical Trials | Fight Colorectal Cancer
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?: Molecular Therapy - Oncolytics
Case Report: Immunotherapy + Vaccine Helps 62-Year-Old with Colorectal Cancer – Consult QD
New targeted therapy and immunotherapy approaches in Phase I clinical trials | MD Anderson Cancer Center
Colon Cancer Clinical Trials | Moffitt
Summoning the Troops to Attack Colon Cancer — The Nexus
Oncolytic viroimmunotherapy for colon cancer in clinical trials. | Download Scientific Diagram
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer | NEJM
PureTech Presents Clinical Trial Design Supporting Wholly Owned Immuno-Oncology Candidate LYT-200 at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting | Business Wire
Immunotherapy Combination Approved for Colorectal Cancer - NCI
Frontiers | Colorectal Cancer Immunotherapy: Options and Strategies | Immunology
Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers | Nature Medicine
Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts - Gastroenterology
Clinical Application of Cytokines in Cancer Immunotherapy | DDDT
Genomics and emerging biomarkers for immunotherapy of colorectal cancer - ScienceDirect
Key immunotherapy trials in metastatic colorectal cancer (CRC). | Download Table
Phase 2 study of pembrolizumab in patients with advanced rare cancers | Journal for ImmunoTherapy of Cancer
